Scientists at UNIGE and HUG have developed CAR-T cells capable of targeting malignant gliomas while preserving healthy tissue ...

They have unique cell surface receptors that are generated ... Here authors show that by looking at epigenetic markers in human CD8 + T cells and CAR-T cells, properties and quality of these ...

Researchers at UNIGE and HUG have created CAR-T cells that can selectively target malignant gliomas, sparing the surrounding healthy tissue. Glioblastoma is the most common and aggressive form of ...

Researchers have developed a promising CAR-T cell therapy targeting glioblastoma, the most aggressive brain tumor.

Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which current treatments remain ineffective. In ...

Also, the panel consists of five different T cell surface markers for T naïve or memory/effector cell phenotyping: CD45RA, CD45RO, CD27 (long-lasting survival), CD95, and CD62L. Improved workflow ...

Phenotype T naive/memory/effector cells using 5 different T cell surface markers CD45RA, CD45RO, CD27 (long term survival), CD62L, and CD95. Measure effector cytokines secreted by activated T cells, ...

By profiling in total 32 epithelial and mesenchymal markers, signaling molecules ... The stimulation of T-cell receptor (TCR) ...

A century after scientists suspected it existed, researchers have uncovered a new type of cell with almost magical abilities ...

Non-specific binding (NSB), the most annoying thing to scientists in the biosensing field, is one of the main factors limiting the performance of diagnostic sensors. The research, titled "New ...

Researchers at the University of Geneva developed CAR T cells targeting the glioblastoma marker PTPRZ1, showing efficacy ...